Searched for
ANALGESICS
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- Government prescribes end to over-the-counter sale of cough syrupsEven in small villages with a population of less than 1,000, where certain remedies including cough syrups were allowed to be sold without ...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Ek Din X reviews out, netizens say Sai Pallavi-Junaid Khan film is not original, but a sweet, out-and-out love story: 'No guns, only roses...'Ek Din, starring Sai Pallavi and Junaid Khan, premiered on May 1, eliciting mixed reactions on social media. While some criticized its stor...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- Sprays, pills, creams...ooh, aah, ouch? India’s pain market is now a Rs 16,000 cr giantIndia’s pain relief market has exploded post-pandemic, doubling to nearly ₹16,000 crore in just five years. From gels and sprays to pills l...
- Supriya Lifesciences Q3 Results: Net profit triples to Rs 30 croreRevenues rose 33% YoY to Rs 140 crore in Q3FY24. Earnings before interest, taxes, depreciation and amortisation (EBITDA) for Q3FY24 almost ...
- Govt to allow sale of some drugs sans prescriptionThe DTAB has approved a list of OTC drugs which includes medicines like antifungal infections, analgesics (pain killers), cough syrups, dec...
- In a race with HCQ, remdesivir and Coronil, Paracetamol has witnessed a sudden rise in demandSudden demand for paracetamol has been taken to be a possible clue to people concealing Covid-19 at home. People who have, or think they ha...
- GSK consumer MD to head residual business post HUL deal completionThe unlisted entity has brands like Sensodyne toothpaste, Crocin analgesic and Iodex pain balm. The majority of GSK Consumer’s India portfo...
- Lupin gets USFDA nod for opioid analgesic tabletsThe company has received final approval from USFDA to market its Oxycodone Hydrochloride tablets USP, in the strengths of 5 mg, 10 mg, 15 m...
- Aurobindo Pharma gets USFDA nod for opioid analgesic tabletsThe approved product is a generic version of Purdue Pharma's Dilaudid tablets in the same strengths, tablets relieve moderate to severe pai...
- Aurobindo Pharma gets USFDA nod for antidote to analgesic overdoseAurobindo Pharma has received final approval from the US health regulator for generic version of an intravenous antidote to a pain-killer d...
- NutraPlus to start commercial production at Tarapur plantDrug firm NutraPlus India will start commercial production at its active pharmaceutical ingredient (API) facility at Tarapur plant.
- Sun Pharma to push Ranbaxy's OTC brands like Revital, Volini, ChericofAccording to top executives from both the companies, Ranbaxy's OTC portfolio is going to be one of the key segments for Sun Pharma with sig...
- Sanofi India launches new product in headache segmentHealthcare service provider Sanofi India, is aiming at a four per cent market share in the headache segment currently valued at Rs 233 crore
- Surya Pharma arm buys US-based ActivOn for USD 22 mnChandigarh-based Surya Pharmaceuticals today said its subsidiary has acquired US-based over-the-counter analgesic drug manufacturer ActivOn...
- Paras fought a dozen copyright cases every yearSince the days of its first successful product Stopache in the ‘80s, Paras Pharmaceuticals has seen copycats aping its flagship brands.
- Lincoln's patent on 'Vivian Roll On' acceptedPharmaceutical company, Lincoln Pharmaceuticals Ltd on Thursday said its application for the patent of Vivian Roll On, the composition comp...
Load More
